Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
LungBeat by LiveLunger is a CE-marked digital health solution for chronic asthma patients. Clinical studies have shown that it improves therapy adherence rates in severe asthma patients receiving biological therapies. The product provides real-time lung function insights and supports daily self-management, with direct communication to healthcare teams. It aims to improve patient outcomes and reduce healthcare costs through better adherence and remote monitoring.
The company seeks clinical partnerships to expand the platform’s features and indications beyond asthma.
No specific drug or biologic clinical trial results are reported; the focus is on digital intervention outcomes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LiveLunger.